1. Home
  2. VSME vs TOVX Comparison

VSME vs TOVX Comparison

Compare VSME & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

HOLD

Current Price

$1.55

Market Cap

7.6M

Sector

N/A

ML Signal

HOLD

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.20

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSME
TOVX
Founded
2013
2001
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
7.3M
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
VSME
TOVX
Price
$1.55
$0.20
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
439.5K
11.0M
Earning Date
04-14-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,483,152.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.17
52 Week High
$64.20
$2.03

Technical Indicators

Market Signals
Indicator
VSME
TOVX
Relative Strength Index (RSI) 83.55 44.12
Support Level $0.07 $0.21
Resistance Level $2.11 $0.22
Average True Range (ATR) 0.07 0.03
MACD 0.20 0.00
Stochastic Oscillator 72.93 24.94

Price Performance

Historical Comparison
VSME
TOVX

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: